Drug Makers Square Off Over Inter Partes Review In Federal Circuit Briefs
WASHINGTON, D.C. — In a May 8 appellee brief, Sanofi Mature IP tells the Federal Circuit U.S. Court of Appeals that the Patent Trial and Appeal Board did not err in...To view the full article, register now.
Already a subscriber? Click here to view full article